Billboard rules baffles DDMAC

Share this article:
“How does the FDA regard signage or billboards advertising pharmaceutical products that are prominently displayed at ballparks and other sports stadiums, and which may be viewed by tens of thousands or even millions of sports fans at televised events? Does such signage come under FDA's authority ... ?” 

This intriguing question from the audience seemed to stump a panel of FDA staffers at the DTC National Conference in Washington in April.

After a pause, Division of Drug Marketing, Advertising, and Communications reviewer Kathryn Aikin spoke for the panel: “Honestly, I don't know the answer to that question. I'm not sure we've ever thought about it. But we'll discuss it back at the office.”
Share this article:
close

Next Article in News

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.